المراجعة النهائية (Ultimate Exam Guide)

مراجعة مركزة وشاملة لامتحانات الـ MCQs باللغة الإنجليزية مدعمة بالكلمات المفتاحية والمقارنات.

L1: Esophagus (Anatomy, Physiology & Benign Diseases)

Embryology & Anatomy

• Embryology: Stomach is separated from pharynx by a primitive constriction (future esophagus). Trachea and esophagus start as a single structure, divided by two lateral septa into trachea in front and esophagus behind.
• Dimensions & Position: 25 cm long muscular tube. Extends from Upper Esophageal Sphincter (UES) (cricopharyngeus muscle) to the cardia of the stomach. Lies in the posterior mediastinum.
• 3 Anatomical Segments:
  • Cervical (C6–T1): Starts 15 cm from incisors. Lacks serosa.
  • Thoracic (T1–T10): Longest segment (20 cm). Turns slightly to the right, courses behind trachea. Lacks serosa (makes it prone to rapid local tumor spread).
  • Abdominal (T10–T11): 1.2–2.5 cm long. Runs below diaphragm. Lies intraperitoneally and is surrounded by serosa.
• 3 Anatomical Constrictions: Important clinically for foreign bodies and strictures: 1) Pharyngoesophageal junction, 2) Aortic arch & left main bronchus crossing, 3) Diaphragmatic junction.
• Important Points: Lack of serosal outer layer (except abdominal part), rich lymphatic drainage, extended venous & arterial blood supply.

Physiology & Evaluation

• Physiology: Initial oral phase is voluntary. Pharyngeal and esophageal phases are involuntary.
• Sphincters: UES protects respiratory passages from regurgitation and stops air entering. Lower Esophageal Sphincter (LES) is a high-pressure zone preventing gastric reflux.
• Contraction Types:
  • Primary: Vagal-controlled coordinated wave following a conscious swallow.
  • Secondary: Normal reflex response to clear a stubborn food bolus or refluxed material (no conscious swallow).
  • Tertiary: Non-peristaltic, infrequent (<10%). Seen during meals on manometry.
• Investigations:
  • Barium Esophagogram (Radiography): Shows narrowing, distortion, or motility issues.
  • Esophagogastroduodenoscopy (EGD) / Endoscopy: Mandatory to view mucosa, obtain biopsy/cytology, remove foreign bodies, and dilate strictures.
  • Endoscopic Ultrasonography (EUS): Details wall layers and mediastinal structures (local staging).
  • Esophageal Manometry: Uses a multi-lumen catheter. Gold standard for diagnosing motility disorders.
  • 24-hour pH monitoring: Gold standard/most accurate method for Gastroesophageal Reflux Disease (GERD). Highly useful for atypical symptoms.

Symptoms & Esophageal Conditions

• Symptoms:
  • Dysphagia: Difficulty swallowing. Sensation of "food sticking".
  • Odynophagia: Pain on swallowing (common in infective/chemical esophagitis).
  • Regurgitation: Return of contents from above an obstruction.
  • Reflux: Passive return of gastroduodenal contents to the mouth (hallmark of GERD).
  • Chest pain: Can mimic angina pectoris.
• Foreign Bodies (F.B): Food bolus is most common (often implies underlying disease). Beware of button batteries (requires urgent removal). Removed via flexible endoscopy (snare, basket, forceps).
• Perforation: Iatrogenic (most common, post-endoscopy) or Boerhaave’s syndrome (spontaneous rupture due to severe vomiting). Surgical emphysema is pathognomonic. Lethal due to mediastinitis. Rx: Conservative (small, stable) or Surgical (large, septic shock).
• Corrosive Injuries:
  • Strong Acid: Produces coagulation necrosis (limits depth of injury).
  • Viscous Alkali: Produces liquefaction necrosis (increased depth of injury).
  • Management: Endoscopy within 24-48h. Nutritional support. Avoid blind gastric tube insertion. Late management (8 weeks): Dilatation for strictures.
• Achalasia: Degenerative motility disorder. Aperistalsis + abnormal relaxation of LES.
  • Diagnosis: Barium shows ‘bird’s beak’ tapering stricture. Manometry (High-Resolution Manometry - HRM) is gold standard. Endoscopy + Biopsy is essential to exclude Pseudoachalasia (malignancy mimicking achalasia).
  • Treatment: Medical (Calcium Channel Blockers, nitrates), Pneumatic balloon dilatation (beware of perforation), Botulinum toxin, Laparoscopic Heller’s myotomy + fundoplication, or Per-oral Endoscopic Myotomy (POEM).

💡 High-Yield Hints (L1)

• 25 cm length & 3 constrictions: The esophagus length and physiological narrowings are key sites for foreign body impaction.
• No Serosa (Except Abdomen): The lack of a serosal layer in the cervical and thoracic esophagus facilitates rapid, early spread of tumors.
• Gold Standards: Esophageal Manometry is the gold standard for motility disorders (like Achalasia). 24-Hour pH monitoring is the gold standard for GERD.
• Surgical Emphysema: If present, it is virtually pathognomonic for a perforated esophagus (a lethal emergency due to mediastinitis).
• Acid vs Alkali: Acids cause coagulation necrosis (limits depth), while alkalis cause liquefaction necrosis (deeper injury). Avoid blind gastric intubation!

L2: Esophagus (Hernias, GERD & Tumors)

Hiatus Hernia & GERD

• Hiatus Hernia Types:
  • Type I (Sliding): Most common. GE junction slides above diaphragm.
  • Type II (Rolling / Paraesophageal): Very uncommon. Defect in phrenoesophageal ligament. Stomach herniates, but GE junction remains anchored in abdomen.
  • Type III (Mixed): Features of both.
• Gastroesophageal Reflux Disease (GERD):
  • Caused by transient Lower Esophageal Sphincter (LES) relaxation & failure of the antireflux barrier.
  • Treatment: Medical (Proton Pump Inhibitors - PPIs). Surgical (narrowing hiatus, fixing stomach below diaphragm, esophageal elongation).

Benign Tumors

• Rare (0.5% - 0.8% of esophageal neoplasms). Classed as mucosal or extramucosal (intramural).
• Leiomyomas: Most common benign tumor.
  • Features: Intramural, occurs in 20-50 age group. >80% occur in middle & lower thirds. Asymptomatic if < 5cm.
  • Radiology: Smooth concave defect with intact mucosa and sharp borders on barium swallow.
  • Important Rule: DO NOT BIOPSY if leiomyoma is suspected. Biopsy causes scarring, which complicates subsequent extramucosal enucleation.
• Polyps (Pedunculated): Arise in cervical esophagus. Long pedicles, can intermittently extrude from mouth. Rx: Endoscopic electrocoagulation or cervical esophagomyotomy.

Malignant Tumors (Cancer)

• Epidemiology: Men > Women (6th-7th decade). High incidence in Asia/Africa.
• Pathology (Histology):
  • Squamous Cell Carcinoma (SCC): ~95% worldwide. Proximal & mid-esophagus. Risk factors: Smoking, alcohol, nitrosamines, achalasia, hot beverages.
  • Adenocarcinoma: 2.5–8% (but incidence is rising rapidly). Distal esophagus & GE junction. Risk factor: Barrett's Esophagus (metaplastic columnar epithelium replacing squamous epithelium).
• Premalignant Conditions: Achalasia, chronic GERD, Barrett's esophagus, corrosive strictures, Plummer-Vinson syndrome.
• Clinical Features: Progressive dysphagia (starts with solids, progresses to liquids), weight loss, hoarseness (involvement of recurrent laryngeal nerve). Persistent chest pain = ominous sign (mediastinal penetration).
• Diagnosis & Staging:
  • Endoscopy + Biopsy: Gold standard.
  • Barium Swallow: Shows irregular mucosal filling defects, annular constrictions (Apple core or Rat tail appearance).
  • EUS (Endoscopic Ultrasound): Best for local T/N staging.
  • CT / PET-CT: Best for distant metastasis spread.
• Management:
  • Early (T1a): Endoscopic mucosal resection.
  • Locally advanced: Neoadjuvant Chemoradiotherapy followed by Surgery (e.g., Ivor Lewis, McKeown, Transhiatal esophagectomy).
  • Palliative: Stenting, feeding jejunostomy.
• Prognosis: Dismal. 5-year survival for Stage IV is < 5%.

💡 High-Yield Hints (L2)

• Type I Hiatus Hernia (Sliding): By far the most common type of hiatus hernia.
• Do NOT Biopsy Leiomyomas: Leiomyomas are intramural. A mucosal biopsy creates scar tissue, making future surgical enucleation extremely difficult.
• Progressive Dysphagia: Dysphagia that starts with solids and advances to liquids is the classic hallmark presentation of an esophageal malignancy.
• SCC vs Adeno: Squamous Cell Carcinoma prefers upper/mid esophagus (caused by smoking/alcohol). Adenocarcinoma prefers lower esophagus (caused by GERD/Barrett's).
• Chest Pain in Malignancy: If a patient with esophageal cancer presents with persistent chest pain independent of meals, it indicates mediastinal invasion (a very bad prognostic sign).

L3: Oncology (Breast Mass & Triple Assessment)

Triple Assessment & Anatomy

• Triple Assessment: Standard approach for breast lesions. High diagnostic accuracy when concordant.
  1. Clinical Evaluation: History (age, duration, pain, discharge, family history) & Physical Exam (palpation of lump and lymph nodes).
  2. Imaging: Ultrasound (young women <40, dense breasts) & Mammography (women >40, detects microcalcifications).
  3. Pathology: Fine Needle Aspiration Cytology (FNAC) or Core Needle Biopsy.
• Axillary Lymph Nodes: 5 anatomical groups (Anterior/Pectoral, Posterior/Subscapular, Lateral/Humeral, Central, Apical).
  • Surgical Levels (relative to Pectoralis Minor): Level I: Lateral. Level II: Behind. Level III: Medial/Apical.

Investigations & BI-RADS

• Labs & Markers: CA 15-3 (most commonly associated with breast carcinoma), CEA. CA 125 (Ovarian), AFP (Liver/Germ cell). Pre-op labs: Complete Blood Count (CBC), LFT, Coagulation profile.
• Imaging Modalities:
  • Mammography: Standard screening >40 yrs. Shows microcalcifications. Disadvantage: Less sensitive in dense breasts/young women. Radiation.
  • Ultrasound: Best for young women. Distinguishes solid from cystic lesions. No radiation.
  • MRI: Highly sensitive for multifocal, multicentric, and occult lesions. Good for implants and high-risk patients. High false-positive rate.
  • PET / CT / Bone Scan: Used for staging advanced disease (detecting metastasis).
• BI-RADS Classification:
  • 0: Incomplete (need more imaging).
  • 1: Negative.
  • 2: Benign finding.
  • 3: Probably benign (<2% malignancy risk, short-term follow-up).
  • 4 (A, B, C): Suspicion for malignancy. Tissue biopsy required.
  • 5: Highly suggestive of malignancy (>95%). Immediate biopsy & treatment.
  • 6: Biopsy-proven malignancy.

TNM Staging Summary

• Tumor (T): T1 (≤ 2cm), T2 (> 2cm to 5cm), T3 (> 5cm), T4 (Invades chest wall or skin, inflammatory carcinoma).
• Nodes (N): N0 (No nodes), N1 (Movable ipsilateral axillary), N2 (Fixed/matted axillary or internal mammary), N3 (Infraclavicular, supraclavicular).
• Metastasis (M): M0 (None), M1 (Distant metastasis present - automatically makes it Stage IV).

💡 High-Yield Hints (L3)

• Triple Assessment Rule: Clinical + Imaging + Pathology. When all three are concordant, the diagnostic accuracy is near 100%.
• Imaging By Age: Ultrasound is the imaging of choice for women under 40 due to dense breasts. Mammography is the standard screening tool for >40.
• Tumor Markers: CA 15-3 is the specific tumor marker for breast cancer monitoring (CEA is also used but is less specific).
• Surgical Levels: Axillary nodes are divided into 3 levels based on their relationship to the Pectoralis Minor muscle (I=Lateral, II=Behind, III=Medial).
• BI-RADS 5 vs 6: BI-RADS 5 is highly suggestive (>95%) requiring immediate biopsy. BI-RADS 6 means the malignancy is already biopsy-proven.

L4: Salivary Gland (Diseases & Tumors)

Anatomy & Non-Neoplastic Disorders

• Anatomy: Major glands (Parotid, Submandibular, Sublingual) & unlimited minor glands. Saliva volume: ~1500 ml/day. Acini (parenchyma) and Myoepithelial cells.
• Acquired Disorders:
  • Xerostomia (Dry mouth): Caused by radiation, autoimmune diseases, anticholinergic drugs, dehydration.
  • Sialorrhea (Excess saliva): Cholinergic agonists, oral infections.
• Infections: Viral (Mumps, HIV, Coxsackie), Bacterial (Staph).
• Sjögren’s Syndrome: Autoimmune. Destroys glands (periductal lymphocytes). Highly associated with progressing to Lymphoma (1 in 6 cases).
• Sialectasis: Progressive destruction of gland alveoli + duct stenosis.
• Plunging Ranula: Rare mucous retention cyst from sublingual/submandibular glands that dives into the neck ("frog belly").

Tumors & Surgical Complications

• Benign Tumors:
  • Pleomorphic Adenoma: Most common benign tumor.
  • Warthin Tumor
  • Oncocytoma
• Malignant Tumors:
  • Mucoepidermoid Carcinoma
  • Adenoid Cystic Carcinoma (notorious for perineural spread).
  • Acinic Cell Carcinoma
  • Squamous Cell Carcinoma (SCC)
  • Carcinoma ex-pleomorphic adenoma (malignant change in a pre-existing benign pleomorphic adenoma).
• Surgical Complications:
  • Parotidectomy: Temporary/Permanent Facial Nerve (CN VII) weakness, Sialocele, permanent numbness of ear lobe (Great Auricular Nerve transection), Frey’s syndrome (gustatory sweating - sweating while eating).
  • Submandibular Excision: Injury to Marginal Mandibular, Lingual, and Hypoglossal nerves. Submental numbness (transection of nerve to mylohyoid).

💡 High-Yield Hints (L4)

• Most Common Tumor: Pleomorphic Adenoma is the most common benign tumor in the salivary glands.
• Sjögren’s Syndrome Danger: It is an autoimmune condition that has a high risk of progressing to Lymphoma (1 in 6 patients).
• Plunging Ranula: A mucous retention cyst arising from the floor of the mouth that extends downwards, mimicking a "frog belly".
• Frey's Syndrome: A specific complication of parotid surgery causing gustatory sweating (sweating while eating) due to aberrant nerve regeneration.
• Nerve Risks: Parotidectomy risks the Facial Nerve (CN VII). Submandibular excision risks Marginal Mandibular, Lingual, and Hypoglossal nerves.

L5: Neck (Cervicofacial Swellings)

Classification & Assessment

• Classification of Neck Masses:
  • Skin/Fascia: Sebaceous cyst, Lipoma.
  • Lymph nodes: Infective, Malignant, Reticuloses.
  • Lymphatics: Cystic hygroma, Lymphangioma.
  • Vascular: Carotid body tumor, Carotid aneurysm.
  • Branchial: Branchial cyst.
  • Thyroid: Thyroglossal cyst/fistula (moves with tongue protrusion).
• Physical Assessment Signs: Palpate for Site, Size, Consistency, Mobility. Check Transillumination (positive in cystic hygroma). Check Pulsatility & Expansibility (aneurysms) or Compressibility (vascular tumors).

Red Flags & Key Points

• Red Flags (Suspicion of Malignancy):
  • Hard, fixed mass.
  • Older patient (>50 years).
  • Progressive unremitting hoarseness or dysphagia.
  • B-Symptoms: Fever, night sweating, and recent weight loss.
• Key Exam Principles:
  • A neck mass in a younger patient with sudden onset is usually benign (infective).
  • Any neck mass in an elderly patient increases the risk of malignancy.
  • Fine Needle Aspiration Cytology (FNAC) is the most useful initial investigation if a neck mass is thought to be malignant.

💡 High-Yield Hints (L5)

• Age Factor: Sudden neck masses in youth are overwhelmingly benign/infective. Any new mass in an elderly patient (>50) is malignant until proven otherwise.
• Physical Signs: Transillumination is a classic sign of Cystic Hygroma. Moving with tongue protrusion indicates a Thyroglossal cyst.
• Malignancy Red Flags: Hard, fixed masses, progressive hoarseness, and "B-symptoms" (fever, night sweats, weight loss) demand urgent investigation.
• Initial Investigation: Fine Needle Aspiration Cytology (FNAC) is the single most useful first-line test for a suspected malignant neck lump.
• Vascular Differentiation: Pulsatility + Expansibility suggests an aneurysm. Compressibility suggests a vascular malformation/hemangioma.

L6: Top 5 Comparisons (High-Yield Tables)

1. Benign vs. Malignant Esophageal Tumors

Feature	Benign Tumors (e.g., Leiomyoma)	Malignant Tumors (e.g., SCC, Adenocarcinoma)
Incidence	Rare (0.5% - 0.8% of esophageal neoplasms).	Highly common (the vast majority of esophageal tumors).
Origin / Layer	Typically extramucosal / intramural (e.g., from muscle).	Arise from the mucosa (epithelium).
Clinical Presentation	Often asymptomatic if < 5cm. Vague pressure if larger.	Progressive dysphagia (solids to liquids), severe weight loss.
Biopsy Protocol	DO NOT BIOPSY (causes scarring that ruins enucleation).	Mandatory via Endoscopy (Gold standard for diagnosis).
Barium Swallow	Smooth concave defect, intact mucosa, sharp borders.	Irregular mucosal filling defects, 'Apple core' or 'Rat tail'.

2. Mammography vs. Breast Ultrasound

Feature	Mammography	Breast Ultrasound
Target Age Group	Standard screening for women > 40 years old.	Preferred for younger women (< 40) and dense breasts.
Primary Strength	Detects microcalcifications and early non-palpable lesions.	Distinguishes solid from cystic lesions. Guides FNAC.
Radiation Exposure	Involves low-dose ionizing radiation.	No radiation exposure.
Disadvantages	Less sensitive in dense breasts; compression discomfort.	Operator-dependent; misses microcalcifications; poor screening tool.

3. Squamous Cell Carcinoma (SCC) vs. Adenocarcinoma (Esophagus)

Feature	Squamous Cell Carcinoma (SCC)	Adenocarcinoma
Location	Proximal and Middle thirds of the esophagus.	Distal third of the esophagus & GE junction.
Prevalence	~95% of cases worldwide.	2.5–8%, but incidence is rising rapidly.
Major Risk Factors	Smoking, alcohol, achalasia, hot beverages, nitrosamines.	Chronic GERD, Barrett's Esophagus, Obesity.
Cellular Origin	Normal squamous epithelium.	Metaplastic columnar epithelium (Barrett's) or submucosal glands.

4. Early vs. Late Management of Corrosive Esophageal Injuries

Feature	Early Management (Acute Phase)	Late Management (Chronic Phase)
Timing	Within 24–48 hours of ingestion.	Starts about 8 weeks after injury.
Core Action	Endoscopic assessment to grade the burn. Nutritional support.	Dilatation (Bouginage or balloon) of formed strictures.
Contraindications	Avoid blind gastric tube insertion & early dilation (causes perforation).	Avoid retrograde dilation without a gastrostomy.
Adjunct Therapies	NG/PEG feeding for severe burns. Surgery if perforated.	Local steroid injections for short, stubborn strictures.

5. Type I (Sliding) vs. Type II (Rolling) Hiatus Hernia

Feature	Type I (Sliding) Hiatus Hernia	Type II (Rolling / Paraesophageal)
Incidence	Most common type.	Very uncommon.
Patho-anatomy	The Esophagogastric (GE) junction slides above the diaphragm.	Stomach herniates beside esophagus; GE junction remains anchored below diaphragm.
Underlying Defect	Laxity of the hiatus and supporting structures.	Isolated weakness or defect in the phrenoesophageal ligament.
Clinical Focus	Strongly associated with GERD symptoms (heartburn, reflux).	Higher risk for strangulation, obstruction, or mechanical issues.